Transformative Partnership: Zydus and Guardant Health Join Forces for Cancer Testing in India and Nepal

▴ Cancer Testing in India
As India and Nepal grapple with the growing burden of cancer cases, initiatives like these are pivotal in steering the healthcare landscape towards innovative solutions and improved patient care

In a remarkable move towards advancing precision medicine, Zydus and Guardant Health have entered into a co-marketing agreement, aiming to promote the Guardant360 portfolio of liquid and tissue biopsy tests across India and Nepal. This collaboration, as announced through an exchange filing, highlights the commitment to enhancing patient outcomes and the field of precision oncology in the region.

Comprehensive Genomic Profiling at the Forefront: The tests highlighted in this partnership include Guardant360 and Guardant360 TissueNext, offering comprehensive genomic profiling (CGP), along with the Guardant360 Response test designed for monitoring treatment response. These cutting-edge tests play a crucial role in providing oncologists with valuable insights to make informed decisions for patients dealing with advanced cancer.

Addressing a Growing Health Challenge: Cancer poses a significant health challenge in India and Nepal, with alarming statistics revealing that one out of nine Indians may develop cancer in their lifetime, and over 20,000 individuals in Nepal are diagnosed with cancer annually. Simranjit Singh, CEO of Guardant Health Asia, Middle East, and Africa, emphasizes the pressing need to tackle this issue.

Innovative Solutions for Improved Patient Care: Guardant360, a minimally invasive liquid biopsy test, stands out by offering comprehensive genomic profiling of solid tumours through the analysis of circulating tumour DNA (ctDNA) from a simple blood draw. Guardant360 TissueNext complements this by providing CGP results from a tumour tissue biopsy, offering actionable information to doctors when tissue testing is necessary. The Guardant360 Response test serves as a vital monitoring tool, enabling oncologists to track a patient's treatment response over time.

A Collective Step Toward Precision Medicine: By pooling their resources and expertise, Zydus and Guardant Health aspire to empower oncologists with the necessary tools to navigate treatment decisions effectively. This collaboration signifies a shared dedication to advancing precision medicine and ultimately making a positive impact on cancer care in the region.

As India and Nepal grapple with the growing burden of cancer cases, initiatives like these are pivotal in steering the healthcare landscape towards innovative solutions and improved patient care. The collaboration between Zydus and Guardant Health marks a significant stride in the realm of precision medicine, offering a ray of hope for cancer patients in India and Nepal. With a focus on comprehensive genomic profiling through tests like Guardant360 and Guardant360 TissueNext, the collaboration addresses the pressing need for precise and informed decision-making in oncology. The inclusion of the Guardant360 Response test further underlines the commitment to monitoring treatment responses over time, ensuring a tailored approach to each patient's journey.

Tags : #zydus #guardanthealth #india #nepal #cancer #cancertesting #patientcare #cancerawareness #medicircle

About the Author


Sunny Parayan

Hey there! I'm Sunny, a passionate writer with a strong interest in the healthcare domain! When I'm not typing on my keyboard, I watch shows and listen to music. I hope that through my work, I can make a positive impact on people's lives by helping them live happier and healthier.

View Profile

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Are we delivering new HIV prevention tools with speed, scale and equity?October 14, 2024
Hospital Lab Management: City Imaging & Clinical Labs to Expand Services to 50 Hospitals in North India by March 2027October 14, 2024
Women at Risk: India’s Breast Cancer Crisis and Its Impact on Future GenerationsOctober 14, 2024
Genetics or Lifestyle: Who’s Really to Blame for Your Premature Hair Loss?October 14, 2024
Decoding Parenthood: How Carrier Screening Can Shape a Healthier Future for India’s FamiliesOctober 14, 2024
Katrina Kaif Presents Kay Beauty’s Velvet Crème Blush: An iconic collectible multi-Use Magic blush in a revolutionary cushion crème-to-powder formulaOctober 11, 2024
Aakash Healthcare goes a step ahead: Movie Shows and Weekend Family Drives for doctors and nurses – Where work-life balance meets fun!October 11, 2024
Not Just a Day, But a Movement: The Real Impact of International Girl Child Day in IndiaOctober 11, 2024
From Darkness to Light: How India Wiped Out a Leading Cause of BlindnessOctober 11, 2024
India’s Diet Could Save the Planet: Why the World Needs to Follow Its Lead by 2050October 11, 2024
Is Your Brain Cleansing Itself? Discover the System That Could Save Your MindOctober 10, 2024
The Dark Side of Desire: How Personality Traits Influence Sexual BehaviorsOctober 10, 2024
India’s Mental Health Time Bomb: Can We Afford to Ignore It Any Longer?October 10, 2024
Go Cheese Announces Strategic Collaboration with Bigg Boss Season 18 to Enhance Brand Engagement and Consumer Reach Across IndiaOctober 10, 2024
DKMS BMST Foundation India Expands Stem Cell Donor Registry with 400+ New Donors registered from IIT DelhiOctober 10, 2024
FLAME University Launches the Centre for Research in Wellbeing and Happiness on International Day of Older PersonsOctober 10, 2024
Kaya Expands in Ludhiana with its 76th Clinic, Elevating Skincare with Advanced Wellness Solutions October 09, 2024
Dr Raj Nagarkar Becomes India’s 1st Oncologist on Cambridge Medical Robotics’ Advisory BoardOctober 09, 2024
Workplace Stress and Burnout Rate Reaching Critical Levels for Indian Employees, Warn ExpertsOctober 09, 2024
Are We Really Living Longer? The Surprising Reality of Life Expectancy TodayOctober 09, 2024